Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients.

Zitt E, Kirsch AH, Haueis M, Strasak A, Neyer U, Mayer G, Rosenkranz AR.

Clin Nephrol. 2011 Apr;75(4):309-18.

2.

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.

Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.

Bone. 2012 Jun;50(6):1266-74. doi: 10.1016/j.bone.2012.02.634. Epub 2012 Mar 6.

PMID:
22425694
3.

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

Slinin Y, Foley RN, Collins AJ.

J Am Soc Nephrol. 2005 Jun;16(6):1788-93. Epub 2005 Apr 6.

4.

Predictors for cardiovascular morbidity and overall mortality in Tunisian ESRD patients: a six year prospective study.

Fellah H, Hammami MB, Feki M, Boubaker K, Abdallah TB, Lacour B, Mebazaa A, Kaabachi N.

Clin Biochem. 2009 May;42(7-8):648-53. doi: 10.1016/j.clinbiochem.2008.12.023. Epub 2009 Jan 8.

PMID:
19166827
6.

Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.

Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH.

Am J Kidney Dis. 2002 Jun;39(6):1245-54.

PMID:
12046038
7.

[The measurement of parathyroid hormone in sera of hemodialysis patients with renal insufficiency by employing the various kinds of parathyroid hormone kits].

Torizumi K, Aibata H, Taniguchi Y, Kiji S, Ueyoshi A, Okamoto Y, Tuda T, Ota K.

Radioisotopes. 1988 Jan;37(1):39-42. Japanese.

PMID:
3375468
8.

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R; RISCAVID Study Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27.

PMID:
18305316
9.

Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.

Kato Y, Yamaguchi S, Yachiku S, Fujisawa M, Kawakami N.

Hinyokika Kiyo. 2004 Nov;50(11):755-62.

11.

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.

Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.

Nephrol Dial Transplant. 2008 May;23(5):1650-8. Epub 2007 Dec 8.

PMID:
18065788
12.

Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.

Fukuoka K, Nakao K, Morimoto H, Nakao A, Takatori Y, Arimoto K, Taki M, Wada J, Makino H.

Nephrology (Carlton). 2008 Jun;13(4):278-83. doi: 10.1111/j.1440-1797.2007.00864.x.

PMID:
18476915
13.

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J.

Circulation. 2009 Jun 2;119(21):2765-71. doi: 10.1161/CIRCULATIONAHA.108.808733. Epub 2009 May 18.

14.

Mild hyperphosphatemia and mortality in hemodialysis patients.

Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P.

Am J Kidney Dis. 2005 Jul;46(1):68-77.

PMID:
15983959
15.
16.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM.

J Am Soc Nephrol. 2004 Aug;15(8):2208-18.

17.

C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa K, Canaud B, Lameire N, Port FK, Pisoni RL.

Nephron Clin Pract. 2011;117(2):c167-78. doi: 10.1159/000320116. Epub 2010 Aug 14.

PMID:
20714167
18.

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.

Am J Kidney Dis. 2008 Sep;52(3):519-30. doi: 10.1053/j.ajkd.2008.03.020. Epub 2008 Jun 2.

PMID:
18514987
20.

[Effects of parathyroid hormone gene polymorphism on cardiovascular mortality].

Tsujimoto Y, Tabata T, Inoue T, Tahara H, Shoji T, Shinohara K, Inaba M, Nishizawa Y.

Clin Calcium. 2005 Sep;15 Suppl 1:106-9; discussion 109. Japanese. Erratum in: Clin Calcium. 2006 Feb;16(2):149-52.

PMID:
16272640

Supplemental Content

Support Center